Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2025-12-24 @ 11:29 PM
NCT ID:
NCT01510756
Brief Title:
Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Official Title:
A Phase II Translational Study of Sorafenib for the Treatment of Chronic Lymphocytic Leukemia Patients
Study:
NCT01510756
Protocol Section:
NCT01510756